BETA vs BIO · rev $8.9M vs rev $2.58B
Beta Technologies, Inc. (BETA) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
BIO (BIO) common stock.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
BETA currently screens at market cap $3.72B. BIO currently screens at market cap $0.
Not investment advice. Open the BETA and BIO stock pages for the full models.
Not investment advice.